Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma

JAMA Otolaryngology - Head and Neck Surgery - United States
doi 10.1001/jamaoto.2016.2168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

The Effect of Adjuvant Chemotherapy on Survival in Patients With Residual Nasopharyngeal Carcinoma After Undergoing Concurrent Chemoradiotherapy

PLoS ONE
Multidisciplinary
2015English

Feasibility and Efficiency of Concurrent Chemoradiotherapy With a Single Agent or Double Agents vs Radiotherapy Alone for Elderly Patients With Esophageal Squamous Cell Carcinoma: Experience of Two Centers

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Treatment Results in Patients With Ductal Carcinoma in Situ Treated With Adjuvant Radiotherapy

Turkish Journal of Medical Sciences
Medicine
2019English

Expression of PIM‑1 in Salivary Gland Adenoid Cystic Carcinoma: Association With Tumor Progression and Patients' Prognosis

Oncology Letters
Cancer ResearchOncology
2017English

Practice Patterns and Outcomes of Chemoradiotherapy Versus Radiotherapy Alone for Older Patients With Nasopharyngeal Cancer

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2019English

Prm21 - Modelling Survival of Patients With Completely Resected Advanced Melanoma With Adjuvant Treatment of Nivolumab Versus Observation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Salivary Gland Carcinoma

2012English

Patterns of Failure and Factors Affecting It in Carcinoma Cervix Stage (Iib – Iva) Treated With Chemoradiotherapy or Radiotherapy Alone.

International Journal of Advanced Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy